stella
beta
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease — Stella
Recruiting
Back to Primary Sjogren's Disease trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(5 sites)
United States
Chicago Clinical Research Institute Inc, Chicago, Illinois
Accurate Clinical Research, Inc., Lake Charles, Louisiana
Novel Research LLC, Bellaire, Texas
Accurate Clinical Research, Inc., Houston, Texas
Velocity Clinical Research, Waco, Waco, Texas
View full record on ClinicalTrials.gov